ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 74 filers reported holding ADMA BIOLOGICS INC in Q3 2019. The put-call ratio across all filers is 3.79 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,045 | +5.0% | 12,303 | +8.3% | 0.00% | 0.0% |
| Q2 2023 | $41,937 | +11.5% | 11,365 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $37,618 | -16.2% | 11,365 | -1.7% | 0.00% | 0.0% |
| Q4 2022 | $44,872 | +157.8% | 11,565 | +61.5% | 0.00% | +100.0% |
| Q3 2022 | $17,404 | -22.9% | 7,162 | -37.2% | 0.00% | 0.0% |
| Q2 2022 | $22,580 | -69.9% | 11,404 | -56.3% | 0.00% | -50.0% |
| Q1 2020 | $75,096 | -11.8% | 26,075 | +36.3% | 0.00% | +100.0% |
| Q3 2019 | $85,106 | – | 19,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |